ReviewClinical and translational allergyPublished
GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management
12 of 56 authors shown in byline order.
Regional connection
Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Publication record
- Type
- Review
- Venue
- Clinical and translational allergy
- Published
- Topic
- Clinical care
- Subject terms
- Desensitization; Immunoglobulin E; Food allergy; Omalizumab; anaphylaxis
- PubMed ID
- 39506193
- PubMed Central ID
- PMC11540805
- Open access
- Yes, open
- Added to directory
- Source checked